Neurology
Conference Coverage
Mutant huntingtin and neurofilament light are potential biomarkers in Huntington’s disease
PHILADELPHIA – The biomarkers successfully distinguish between healthy controls, patients with premanifest disease,...
Conference Coverage
Estimated prevalence of OSA in the Americas stands at 170 million
The United States has the greatest burden of OSA in the Americas, with an estimated 54 million cases.
Conference Coverage
Balancing privacy, protection in at-risk MS patients
SEATTLE – Keep HIPAA, state laws, and professional guidelines in mind as you consider confidentiality’s limits, an attorney and neuroethics fellow...
News
Opioid prescriptions declined 33% over 5 years
The number of opioid prescriptions decreased 33% nationally from 2013 to 2018, according to the new report from the American Medical Association...
News
Treatment for hepatitis C reduces risk of Parkinson’s disease
Data support the hypothesis that hepatitis C virus infection is a risk factor for incident Parkinson’s disease.
Conference Coverage
DOACs surpass warfarin in low-weight AFib patients
SAN FRANCISCO – Data from 21,000 Korean AFib patients weighing 60 kg or less showed DOACs had better efficacy and safety than did warfarin.
Video
Developing new measurements for better MS outcomes
SEATTLE – Researchers are working on developing more sensitive ways of measuring MS disease status.
Conference Coverage
Meta-analysis finds no link between PPI use and risk of dementia
SAN DIEGO – In the absence of randomized trial evidence, a PPI prescribing approach based on appropriate use appears sufficient.
Conference Coverage
MS patients pay big price for breaks from DMT
SEATTLE – They suffer more relapses, hospitalizations, and ER visits, a study finds, and nondrug costs are higher.
Conference Coverage
Hazardous cannabis use in MS linked to anxiety, depression
SEATTLE – But it is not clear if there is a cause-and-effect relationship.